Registered entities
PRELUDE THERAPEUTICS, INC.
Reg. No. 811384762United States
PRELUDE THERAPEUTICS INC
Reg. No. 1678660United States
Prelude Therapeutics Inc.
Reg. No. 81-1384762United States
Innovation
64 patent families (15 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,325 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 17 |
| 2023 | 24 |
| 2024 | 20 |
| 2025 | 30 |
| 2026 | 4 |
Social engagement
Social engagement: 10.7K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
3 investors on record; lead investors include Orbimed, Fidelity Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Recent activity
22 Apr 2026
Leadership hire
Chief Medical Officer
17 Mar 2026
Event
AACR 2026
3 Nov 2025
Event
ASH